Liver, Pancreas, Esophagus, Gallbladder

66 Expert Conversations

    66 Expert Conversations
    Future of liver disease treatment. Xenotransplantation of liver. 14
    Future in esophageal cancer treatment. Precision medicine. Tumor genome sequencing. 10
    How to improve health of your liver? Difficulty to keep low weight. 16
    Liver cancer risk and fatty liver disease. Cancer screening in NASH, NAFLD. 10
    How NASH differs from NAFLD. What drives progression to NASH? 5
    Esophageal carcinoma radiotherapy. ‘East’ vs. ‘West’ differences in radiotherapy use. 7
    Does GERD anti-reflux surgery reduce esophageal cancer risks? The risk does not go down to zero. 2
    Genetic tests to find risks for liver disease [NAFLD and NASH]. 6
    Esophageal carcinoma diagnosis. PET CT. Endoscopic ultrasound. Cure at early stage is possible. 5
    Gut microbiome and fatty liver disease. NAFLD, NASH, and Fecal transplantation. 7
    Esophageal cancer treatment FAQ. Prognosis. When surgery is not beneficial? 11
    Esophageal carcinoma risks and symptoms. ‘East’ vs. ‘West’ differences in esophageal cancer. 4
    Can fatty liver disease be reversed? NAFLD and NASH treatment. 4
    FAQ from patients with fatty liver disease. Life quality, prognosis, alcohol use. 15
    Food supplements and generic drugs for NASH and NAFLD. 8
    Gastroesophageal reflux disease and esophageal cancer. 1
    Esophageal carcinoma. Minimally invasive surgery vs. classic surgery. Surgeon’s skill is paramount. 8
    GERD anti-reflux surgery often fails after 10 years. PPI medications and esophageal cancer risk. 3
    Most patients with fatty liver disease & NASH do not have symptoms. Alcohol is often not to blame. 17
    Leading drug candidates for NASH therapy. NAFLD, fatty liver disease treatment. 12
    When new drugs will be approved for fatty liver disease? 11
    Diagnostic tests for fatty liver disease, NAFLD. FibroScan and MR Elastography. 3
    Non-obese patients with NAFLD [fatty liver disease]. ‘Lean NASH’. 2
    Esophageal carcinoma. Neoadjuvant chemotherapy vs. upfront surgery. 6
    Dr. Jari Rasanen. Esophageal cancer and Lung cancer expert. Biography. 0
    Coffee reduces risks of liver disease. Coffee and NAFLD prevention. 13
    Hepatic Stellate Cells cause fatty liver disease. NAFLD and NASH causes. 9
    What is Non-Alcoholic Fatty Liver Disease? NAFLD Diagnostic Criteria. 1
    Dr. Scott L Friedman. Liver disease, NAFLD, NASH Expert. Biography. 0
    Patient’s story. Metastatic esophageal cancer. Success of double neoadjuvant chemotherapy. 12
    Cancer surgery failures and challenges. Ovarian cancer. Eminent cancer surgeon.
    Hypertension in diabetes and in metabolic syndrome. Best treatment options. 2
    Pancreatic cancer screening. Liver cancer screening. 10
    MRI of liver. MRCP of pancreas. MRCP or ERCP? 9
    Chemotherapy selection for metastatic peritoneal cancer. Precision medicine selection. 14
    How to overcome skeptics in work and in life? Leading cancer surgeon explains. 9
    Stage 4 colon cancer. Liver or lung metastases. Locoregional treatment. DEBIRI TACE, IRE, SIRT. 7
    Gallbladder cancer treatment options. 7
    Best surgical treatment for liver cancer. Surgical technique from Japan. 5
    Pancreatic cancer. Quality of life depends on local control of tumor. 4
    Recently viewed Expert Conversations